citalopram has been researched along with reserpine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (39.13) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Suzuki, H; Yomono, HS; Yoshioka, K | 1 |
| Gibb, JW; Hanson, GR; Ritter, JK; Schmidt, CJ | 1 |
| Nowak, G; Pawłowski, L | 1 |
| Fuller, RW | 1 |
| Ask, AL; Ross, SB | 1 |
| Lingjaerde, O | 1 |
| Górka, Z; Mazela, H; Nowak, G; Pawlowski, L | 1 |
| Maj, J; Rogóz, Z; Skuza, G | 1 |
| Mazela, H; Pawłowski, L | 1 |
| Maj, J; Rogóz, Z; Skuza, G; Sowińska, H | 1 |
| Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
| Hjorth, S; Pettersson, G | 1 |
| Gobbi, M; Mennini, T; Palacios, JM; Pompeiano, M; Regondi, MC | 1 |
| Abel, EL | 1 |
| Costentin, J; Leroux-Nicollet, I; Naudon, L; Raisman-Vozari, R; Vilpoux, C | 1 |
| Ross, SB; Stenfors, C; Yu, H | 1 |
| Brocco, M; Dekeyne, A; La Rochelle, CD; MacSweeny, C; Millan, MJ; Papp, M; Peglion, JL | 1 |
| Al-Shafei, AI; Daoud, NN; El-Gendy, OA; Zaazaa, AM | 1 |
3 review(s) available for citalopram and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
From clomipramine to mianserin: therapeutic relevance of interactions with serotonin uptake and storage, as studied in the blood platelet model.
Topics: Antidepressive Agents; Biological Transport; Blood Platelets; Blood Proteins; Citalopram; Clomipramine; Cytoplasmic Granules; Depression, Chemical; Humans; Imipramine; Kinetics; Propylamines; Protein Binding; Reserpine; Serotonin | 1985 |
20 other study(ies) available for citalopram and reserpine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Serotonergic fibers induce a long-lasting inhibition of monosynaptic reflex in the neonatal rat spinal cord.
Topics: 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Biogenic Amines; Citalopram; Electrophysiology; Female; In Vitro Techniques; Ketanserin; Male; Nerve Fibers; Phentolamine; Rats; Rats, Inbred Strains; Reflex, Monosynaptic; Reserpine; Serotonin; Spinal Cord | 1992 |
Dopamine-mediated increases in nigral substance P-like immunoreactivity.
Topics: Animals; Citalopram; Clomipramine; Corpus Striatum; Dopamine; Male; Methamphetamine; Nalidixic Acid; Naphthyridines; Nomifensine; Propylamines; Radioimmunoassay; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Substance P; Substantia Nigra | 1985 |
Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
Topics: Animals; Apomorphine; Body Temperature; Brain; Citalopram; Desipramine; Male; Maprotiline; Mice; Monoamine Oxidase Inhibitors; Norepinephrine; Piperidines; Propylamines; Reserpine; Serotonin Antagonists; Thyrotropin-Releasing Hormone; Tyramine | 1987 |
Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
Topics: Animals; Citalopram; Deamination; Hypothalamus; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Phenethylamines; Propylamines; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Serotonin Antagonists; Synaptosomes | 1987 |
Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
Topics: Animals; Antidepressive Agents; Brain; Citalopram; Drug Interactions; Imipramine; Male; Mice; Norepinephrine; Propylamines; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Thyrotropin-Releasing Hormone; Tyramine | 1985 |
5-Hydroxytryptamine uptake inhibitors antagonize the antireserpine effects of noradrenaline uptake inhibitors.
Topics: Animals; Brompheniramine; Citalopram; Fluvoxamine; Male; Mice; Motor Activity; Norepinephrine; Oximes; Propylamines; Reserpine; Serotonin Antagonists; Tetrabenazine; Zimeldine | 1983 |
Norzimelidine, a metabolite of a highly selective 5-hydroxytryptamine uptake inhibitor, can inhibit the uptake of noradrenaline in-vivo.
Topics: Animals; Antidepressive Agents; Apomorphine; Body Temperature; Citalopram; Male; Mice; Norepinephrine; Propylamines; Reserpine; Thyrotropin-Releasing Hormone; Zimeldine | 1984 |
The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Topics: Animals; Apomorphine; Body Temperature; Citalopram; Desipramine; Fluoxetine; Male; Maprotiline; Mice; Norepinephrine; Propylamines; Reserpine; Serotonin Antagonists | 1983 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Topics: Animals; Brain; Calcium; Citalopram; Hippocampus; Hydroxyindoleacetic Acid; Male; Neurons; Nicotinic Acids; Piperazines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration of 5-HT1A receptors and 5-HT uptake sites in the rat brain.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoradiography; Brain; Citalopram; Male; Nerve Degeneration; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reserpine; Serotonin | 1994 |
Alpha-adrenergic receptors mediate imipramine/alarm substance-induced reaction in rats.
Topics: Animals; Arousal; Brain; Citalopram; Clonidine; Dose-Response Relationship, Drug; Imipramine; Male; Norepinephrine; Nortriptyline; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-2; Receptors, GABA; Reserpine; Serotonin; Yohimbine | 1994 |
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain.
Topics: Animals; Autoradiography; Binding Sites; Biological Transport; Brain; Citalopram; Dopamine; Immunohistochemistry; In Situ Hybridization; In Vitro Techniques; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Norepinephrine; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Animals; Citalopram; Dose-Response Relationship, Drug; Hippocampus; Hypothalamus; Mice; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2001 |
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Discrimination, Psychological; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Postural Balance; Rats; Rats, Wistar; Reaction Time; Reboxetine; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2001 |
Neuroprotective role of Bacopa monnieri extract in modulating depression in an experimental rat model.
Topics: Animals; Bacopa; Brain-Derived Neurotrophic Factor; Citalopram; Depression; Dopamine; Humans; Male; Norepinephrine; Plant Extracts; Rats; Reserpine; Serotonin | 2022 |